HC Wainwright sees Zevra's Miplyffa launch and EU plans driving upside, initiating coverage with a $26 target and Buy rating ...

AMZA is an actively managed ETF designed to combine the income-generating power of MLPs with a more investor-friendly, liquid ...

Liquidia shipped its first FDA-approved product, Yutrepia for pulmonary hypertension in June entering market worth several ...